BMJ  2005;330:681-682 (26 March), doi:10.1136/bmj.330.7493.681

Editorial

Highly active antiretroviral therapy

Exhaustion of treatment options is a challenge that can be delayed

The first 150 words of the full text of this article appear below.

An HIV infected person can possibly live a normal lifespan today, provided she or he takes highly active antiretroviral therapy and takes it perfectly. As pointed out by Sabin et al in this issue,¹ even though new drugs are available each year, a noteworthy proportion of people are at risk of exhausting their treatment options. This proportion is only an imperfect surrogate of the presence of mutations giving rise to resistance to antiretrovirals. For an increasing number of patients, identifying a new regimen that could lower the HIV viraemia, increase the CD4 cell count, and prevent clinical progression is somewhat complicated. Looking at reasons why a current regimen is no longer working may help to make the available options clearer.

Suboptimal adherence to treatment is the most common and crucial reason for failing an antiretroviral regimen. Taking treatment at the correct time, not missing doses or drug holidays, and . . . [Full text of this article]

Department of Infectious Diseases, Catholic University of Rome, 8-00168, Rome, Italy (ritamurri@libero.it)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Hit parade
BMJ 2005 330: 1396. [Extract] [Full Text]

Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study

Caroline A Sabin, Teresa Hill, Fiona Lampe, Ryanne Matthias, Sanjay Bhagani, Richard Gilson, Mike S Youle, Margaret A Johnson, Martin Fisher, George Scullard, Philippa Easterbrook, Brian Gazzard, Andrew N Phillips on behalf of the steering committee of the UK Collaborative HIV Cohort Study Group
BMJ 2005 330: 695. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Accessible Antiretroviral Drugs

Matiram Pun
bmj.com, 25 Mar 2005 [Full text]

HAART- what is the best way?

DR. ANIRBAN DEB
bmj.com, 27 Mar 2005 [Full text]

Re: HAART- what is the best way?

Nicholas Bennett
bmj.com, 30 Mar 2005 [Full text]

Online poll

Find out more here>> and here>>